Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) November 22, 2026
Alterome Therapeutics Presents Preliminary Clinical Data from Ongoing Phase 1/1b Trial of ALTA3263 Demonstrating Antitumor Activity in KRAS-Mutant Colorectal and Pancreatic Cancers at the 38th EORTC-NCI-AACR Symposium November 22, 2026
Herbalife CFO to Participate in Fireside Chat at Bank of America Leveraged Finance Conference on December 1 November 22, 2026
MasTec Enters into Definitive Agreement to Acquire Murphy Corporation, a Leading Mechanical Contractor Serving Mission-Critical End Markets November 22, 2026
NMG Receives Continued Listing Standard Notification from the New York Stock Exchange November 22, 2026
United Therapeutics Corporation Announces First Transplant in EXTEND Clinical Trial of UThymoKidney™ in Patients with End-Stage Renal Disease November 22, 2026